Skip to content
MomMetabolicEVIDENCE-FIRST METABOLIC HEALTH
Menu
Partner · Grade C

SkinnyRx review

Written by Elena Voss, Metabolic Health Editor

Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.

A $99 first month for either injection, with the ongoing price shown only at checkout, and a real non-injection option most providers we review skip: sublingual tablets for both molecules — but the FDA issued its parent entity, Lean Rx, Inc., a warning letter on 02/20/2026 (ref. 717989) for mislabeling itself as the compounder on its own product images and for marketing language implying its compounded products share FDA-approved status with Mounjaro and Zepbound, which they don't. Confirmed directly on FDA.gov; SkinnyRx's own site never mentions it.

See plans at SkinnyRx
  • Confirm HSA / FSA coverage
  • Public signup path reviewed
  • Confirm your total cost

We may earn a referral fee

SkinnyRx at a glance

Semaglutide
$99 first month; standing monthly price not published before checkout
Tirzepatide
$99 first month; standing monthly price not published before checkout
Coverage
Not disclosed on the public site we reviewed
Brand-name
Compounded only

How we scored SkinnyRx

Every factor comes from SkinnyRx's own published pricing, disclosures and oversight, and the six combine into the 37/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.

Postpartum & breastfeeding guidance18/100 · Weak

No postpartum or breastfeeding framing — a generic weight program.

PCOS & hormonal fit24/100 · Weak

Thin on the hormonal picture that drives many mothers' weight.

Clinical oversight & labs26/100 · Weak

Oversight and lab support fall short of the best on our list — the review below says exactly where.

True monthly cost66/100 · Weak

Cost is unpredictable or sits at the premium end.

Ongoing support48/100 · Weak

Support is thin once the prescription ships.

Cancellation fairness60/100 · Weak

Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.

How we checked this review

$99 for the first month of either injection, $149 for semaglutide tablets and $199 for tirzepatide tablets. SkinnyRx doesn't post the ongoing monthly price publicly; you see it at checkout, after the quiz. No state list and no exclusions are published anywhere on the public site, which is the main thing left unanswered before you start.

What to expect when you sign up

We walked SkinnyRx's public signup — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.

  1. 1Product pages show a first-month price for each form: $99 for either injection, $149 for semaglutide tablets, $199 for tirzepatide tablets
  2. 2Complete an online quiz-based intake
  3. 3A licensed provider reviews and prescribes if appropriate
  4. 4Medication ships if approved

What we noticed

  • Offers a genuine choice most providers we review don't: sublingual tablets alongside the injectable, for both molecules
  • The ongoing monthly price isn't posted on any public page; it appears at checkout, after the quiz
  • No state list or exclusions are published anywhere we could find on the public site
  • The site itself makes no mention of its own FDA warning letter — that fact came from FDA.gov, not SkinnyRx's own copy

Pricing

MedicationPricePlan
Compounded semaglutide$99Injection, first month offerA first-month offer. SkinnyRx does not post its standing monthly price publicly; you see it at checkout, after the quiz.
Oral semaglutide$149Sublingual tablets, first month offerFirst month only. The ongoing price appears at checkout.
Compounded tirzepatide$99Injection, first month offerA first-month offer. The standing monthly price appears only at checkout.
Oral tirzepatide$199Sublingual tablets, first month offerFirst month only. The ongoing price appears at checkout.

Swipe the table to see plan details →

Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what SkinnyRx's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.

Prices move. Check today's number for your dose.See plans at SkinnyRx

What we like

  • Offers sublingual tablets as a genuine alternative to injections for both molecules — uncommon
  • A low first month: $99 for either injection

The caveats

  • No state list or exclusions published anywhere on the public site
  • Only first-month prices are public; the ongoing monthly price appears at checkout, after the quiz
  • No mention anywhere of pregnancy, breastfeeding, postpartum recovery, or PCOS
  • The FDA issued its parent company, Lean Rx, Inc., an FDA warning letter dated 02/20/2026 (ref. 717989) for mislabeling itself as the compounder on its own product images and for marketing claims implying its compounded products share FDA-approved status with brand-name drugs like Mounjaro and Zepbound, which they don't — confirmed on FDA.gov, and never mentioned anywhere on SkinnyRx's own site

Weighed the likes and the caveats? See the plans for yourself.See plans at SkinnyRx

The advertised entry price is not the ongoing budget

SkinnyRx advertises $99 for the first month of either compounded injection. Its product offers also show sublingual semaglutide tablets at $149 for the first month and tirzepatide tablets at $199. The standing charge is not published on those offer pages; it appears later in the purchase path. That leaves a practical gap for someone trying to estimate several months of treatment before sharing medical information.

Use the first-month figure to understand the promotion, not to calculate a year of care. Before paying, obtain the recurring medication amount, any care fee, the quantity dispensed and the charge interval. Also ask whether the price changes with dose. Previously published amounts should not be assumed to be today’s renewal quote when the current offer explicitly separates the first month from the price shown at checkout.

There is a specific FDA warning letter

FDA issued warning letter 717989 to Lean Rx, Inc. dba SkinnyRx. The letter identifies SkinnyRx’s own website and discusses product labels presenting SkinnyRx as the compounder, along with marketing claims that implied compounded products shared FDA-approved status with brand-name medicines such as Mounjaro and Zepbound. This is a documented action concerning this business, rather than an inference from a similarly named seller.

A warning letter is important information about the conduct FDA identified. It should not be rewritten as a recall, a blanket finding about every dispensing pharmacy or proof of a particular patient outcome. Equally, a low introductory price does not answer the concerns raised in the letter. Read the regulatory history alongside the current prescribing, pharmacy and payment disclosures, and ask the provider directly about anything that remains unclear.

Sublingual tablets are a separate product choice

A genuine distinction in the public menu is the choice between injections and sublingual tablets for both molecules. For someone reluctant to inject, that creates an additional option to discuss with a clinician. It does not establish that a compounded sublingual formulation is interchangeable with an FDA-approved oral medication, or that the injection’s dosing, effectiveness or evidence can simply be transferred to the tablet.

The oral and injectable offers also have different introductory prices. A comparison that uses the cheapest tablet or injection interchangeably would obscure which treatment the reader is actually shopping for. Ask the prescriber to identify the formulation, dosing instructions and pharmacy, and ask the seller to quote the ongoing price of that exact product. This is particularly important where the advertised first month makes several distinct treatments look similarly inexpensive.

Availability and follow-up remain questions to settle

Its service description outlines a quiz-based intake, licensed-provider review and shipment if approved. That description is a proposed workflow, rather than a guarantee of approval or a particular clinical experience. No state list or exclusions were published on its public offer pages, so nationwide-looking marketing should not be treated as confirmation that a particular medication can be sent to your address.

The site does not publish pregnancy, breastfeeding, postpartum or PCOS guidance on the public pages. That absence does not tell us what a clinician might ask privately, but it prevents treating SkinnyRx as a demonstrated maternal-care specialist. SkinnyRx may remain relevant to someone investigating a compounded sublingual option, provided the formulation and full recurring bill are confirmed first. Someone who needs an open maintenance-price ladder before beginning intake has a clear reason to keep comparing. The published methodology explains why the introduction, the ongoing cost and the regulatory disclosure belong in separate parts of that decision.

The bottom line for mothers

Best for: Mothers willing to verify SkinnyRx's compounding and ingredient claims for themselves rather than take its labels or marketing at face value — the FDA found the site misrepresents who actually compounds these products and implies an FDA-approved status they don't have. Read the FDA's letter before you weigh in the tablet option or the first-month offer.

Alternatives to SkinnyRx

These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.

  • CoreAge RxFeatured partner

    CoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.

    Visit CoreAge Rx
  • Physician-founded and genuinely cheap, with both molecules in a lozenge or a shot and a free MD visit — but a February 2026 FDA misbranding letter is a caveat a mother should read before signing up.

    Visit Strut Health
  • Current public pages do not establish the full semaglutide and tirzepatide plan prices. Earlier recorded prices retain their original verification date; confirm the complete quote and renewal terms before sharing intake details.

    Visit HumeCare+

Providers like SkinnyRx

Keep comparing SkinnyRx

SkinnyRx, answered

Does SkinnyRx offer a non-injection option?
Yes — sublingual tablets are available for both semaglutide and tirzepatide, alongside the injections. The first month is $149 for semaglutide tablets and $199 for tirzepatide tablets; the ongoing price appears only at checkout.
What does SkinnyRx cost after the first month?
SkinnyRx advertises a $99 first month for either injection, but it doesn't post the standing monthly price on any public page. You see it at checkout, after the quiz, so read that figure and the renewal terms before you pay.
Does SkinnyRx have an FDA warning letter?
Yes — the FDA issued one dated 02/20/2026 (ref. 717989) to Lean Rx, Inc., SkinnyRx's legal entity, after reviewing SkinnyRx's website in December 2025. It found the site's product labels falsely display "SkinnyRx" as the compounder of its semaglutide and tirzepatide products, and that marketing lines like "from the same family as GLP-1 treatments like Mounjaro and Zepbound" wrongly imply FDA-approved status for products that don't have it. We confirmed this directly on FDA.gov; SkinnyRx's own site makes no mention of it.

Have a question we didn't answer? SkinnyRx's team can.See plans at SkinnyRx

Pricing, states and verification reflect SkinnyRx's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.

← Back to all providers